Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Balasamy Thiyagarajan"'
Autor:
Kenneth Dickstein, George Klinger, Divakar Sharma, Robert Segal, Bertram Pitt, Günter A.J. Riegger, James D. Neaton, Felipe Martinez, Balasamy Thiyagarajan, A. John Camm, Marvin A. Konstam, Philip A. Poole-Wilson
Publikováno v:
Journal of Cardiac Failure. 5:146-154
Background: In the Evaluation of Losartan in the Elderly (ELITE) heart failure study, a survival benefit (primarily because of a reduction in sudden deaths) was observed in symptomatic patients treated with losartan compared with captopril. Methods a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e0ac4ed5174908652dd8403ec256ba6
https://doi.org/10.1016/s1071-9164(99)90037-4
https://doi.org/10.1016/s1071-9164(99)90037-4
Publikováno v:
Statistics in Medicine. 11:1333-1342
The 75/75 rule was originally proposed by the U.S. Food and Drug Administration (FDA) as an alternative means of testing the bioequivalence of two formulations of a pharmaceutical agent. The rule specified that the ratio of test-to-reference formulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::678a1b22d2bbb978aa6816dbd7845e14
https://doi.org/10.1002/sim.4780111007
https://doi.org/10.1002/sim.4780111007
Publikováno v:
Journal of biopharmaceutical statistics. 14(3)
In some HIV clinical trials, the proportion of patients who achieve treatment success at a clinically meaningful time point (e.g., 16 or 24 weeks) and the subsequent durability of the treatment success after that time point are collected from two exc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c6ce1cb7b368caff01b1a1fa8035ab3
https://pubmed.ncbi.nlm.nih.gov/15468762
https://pubmed.ncbi.nlm.nih.gov/15468762
Autor:
Felipe Martinez, Kenneth Dickstein, A. John Camm, Günter A.J. Riegger, Philip A. Poole-Wilson, Robert Segal, Balasamy Thiyagarajan, Marvin A. Konstam, Divakar Sharma, Bertram Pitt, James D. Neaton, George Klinger
Publikováno v:
Lancet (London, England). 355(9215)
Summary Background The ELITE study showed an association between the angiotensin II antagonist losartan and an unexpected survival benefit in elderly heart-failure patients, compared with captopril, an angiotensin-converting-enzyme (ACE) inhibitor. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1baa129e7fb240a6924de37810be56d
https://pubmed.ncbi.nlm.nih.gov/11022949
https://pubmed.ncbi.nlm.nih.gov/11022949
Autor:
M.A. Konstam, G. Riegger, George Klinger, D. Sharma, R. Segal, F.A. Martínez, J. Neaton, B. Pitt, Balasamy Thiyagarajan, K. Dickstein, A.J. Camm, P.A. Poole-Wilson
Publikováno v:
Hipertensión y Riesgo Vascular. 18:52-53
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1489eaab2252df184e0f9daa96553384
https://doi.org/10.1016/s1889-1837(01)71109-9
https://doi.org/10.1016/s1889-1837(01)71109-9
Autor:
S. Shahinfar, Balasamy Thiyagarajan, Fredric L. Coe, Alexandra D. Carides, Y. Nakagawa, Joan H. Parks, Roger L. Simpson
Publikováno v:
Hipertensión y Riesgo Vascular. 17:130
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aec765ada07f830d5ad025dd07698398
https://doi.org/10.1016/s1889-1837(00)71030-0
https://doi.org/10.1016/s1889-1837(00)71030-0
Publikováno v:
Controlled Clinical Trials. 12:683
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbdb2253487c7b53a80d08e0dc96e7e2
https://doi.org/10.1016/0197-2456(91)90245-h
https://doi.org/10.1016/0197-2456(91)90245-h